The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Global burden of hepatitis B virus: current status, missed opportunities and a call for action
Abstract
Chronic hepatitis B virus (HBV) infection affects about 296 million people worldwide and is the leading aetiology of cirrhosis and liver cancer globally. Major medical complications also include acute flares and extrahepatic manifestations. In addition, people living with HBV infection also experience stigma. HBV-related cirrhosis resulted in an estimated 331,000 deaths in 2019, and it is estimated that the number of deaths from HBV-related liver cancer in 2019 was 192,000, an increase from 156,000 in 2010. Meanwhile, HBV remains severely underdiagnosed and effective measures that can prevent infection and disease progression are underutilized. Birth dose coverage for HBV vaccines remains low, particularly in low-income countries or regions where HBV burden is high. Patients with HBV infection are inadequately evaluated and linked to care and are undertreated worldwide, even in high-income countries or regions. Despite the goal of the World Health Organization to eliminate viral hepatitis as a public health problem by 2030, the annual global deaths from HBV are projected to increase by 39% from 2015 to 2030 if the status quo remains. In this Review, we discuss the current status and future projections of the global burden of HBV infection. We also discuss gaps in the current care cascade and propose future directions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Acute viral hepatitis (types A to E) is primarily characterized by acute inflammatory lesions in liver tissue, including hepatocellular degeneration, necrosis, and infiltration of various inflammatory cells, accompanied by significant hepatocyte regeneration [45].”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [45]
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306
Lok, A. S. F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,087
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
Razavi-Shearer, D., Gamkrelidze, I., Nguyen, M. H., Chen, D.-S., Van Damme, P., Abbas, Z., Abdulla, M., Abou Rached, A., Adda, D., Aho, I., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30056-6 · Cited by 1,661
Self-citationSocioeconomic Disparities in Health in the United States: What the Patterns Tell Us
Braveman, P. A., Cubbin, C., Egerter, S., Williams, D. R., & Pamuk, E. (2010) · American Journal of Public Health · doi:10.2105/ajph.2009.166082 · Cited by 1,548
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Thio, C. L., Seaberg, E. C., Skolasky, R., Phair, J., Visscher, B., Muñoz, A., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11913-1 · Cited by 1,099
Li, J., Zou, B., Yeo, Y. H., Feng, Y., Xie, X., Lee, D. H., Fujii, H., Wu, Y., Kam, L. Y., Ji, F., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30039-1 · Cited by 1,031
Self-citationGenome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N. P., Lee, W. H., Ariyaratne, P. N., Tennakoon, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2295 · Cited by 991
Research works printed but not linked: 1
- United Nations Conference on Trade and Development. List of Least Developed Countries. UNCTAD https://unctad.org/topic/least-developed-countries/map (2022).
Cited by
Cancer incidence and mortality in China, 2016
Zheng, R., Zhang, S., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.02.002 · Cited by 1,494
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
Huang, D. Q., Singal, A. G., Kanwal, F., Lampertico, P., Buti, M., Sirlin, C. B., Nguyen, M. H., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00818-8 · Cited by 189
“Despite the availability of effective antiviral therapy that substantially reduces the risk of HCC, only a minority of treatment-eligible patients receive antiviral treatment because hepatitis B is severely underdiagnosed 23,125–129 .”
BackgroundSelf-citationYounossi, Z. M., Stepanova, M., Shabeeb, R. Q. A., Eberly, K. E., Shah, D., Nguyen, V., Ong, J. P., Henry, L. L., & Alqahtani, S. A. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000352 · Cited by 187
“[3,4] In contrast to candidates with HCC who underwent liver transplant, liver transplant candidates without HCC These trends may be reflective of the new changes in the transplant policy where not only are the sickest patients allocated to the top of the waiting list but organs are allowed to be…”
ResultMak, L.-Y., Liu, K., Chirapongsathorn, S., Yew, K. C., Tamaki, N., Rajaram, R. B., Panlilio, M. T., Lui, R., Lee, H. W., Lai, J. C.-T., et al. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00967-4 · Cited by 182
“The Asia-Pacific region bears the greatest burden of HBV infection globally 21 .”
Self-citationNaik, P. A., Yeolekar, B. M., Qureshi, S., Yeolekar, M. A., & Madzvamuse, A. (2024) · Nonlinear Dynamics · doi:10.1007/s11071-024-09653-1 · Cited by 161
“There are five major hepatitis viruses, called A, B, C, D, and E [2,3].”
Metadata
- Authors
- Hsu, Y.-C., Huang, D. Q., & Nguyen, M. H.
- Affiliations
- Fu Jen Catholic University (TW)
- National University of Singapore (SG)
- Stanford Medicine (US)
- Corresponding author
- Hsu, Yao-Chun
- Nguyen, Mindie H.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2023-04-06
- Volume
- 20
- Issue
- 8
- Pages
- 524-537
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W4362670532
- Cited by
- 632
- References
- 178
- Citations by year
- 2026: 199 · 2025: 226 · 2024: 177 · 2023: 30
- FWCI
- 24.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- hepatitis B virus, global burden of disease, HBV-related liver cancer, hepatitis B cirrhosis, cascade of care, underdiagnosis, missed opportunities, viral hepatitis elimination, mortality projections, extrahepatic manifestations
- MeSH terms
- Hepatitis B, Hepatitis B virus, Humans, Liver Cirrhosis, Liver Neoplasms, Hepatitis B Vaccines, Hepatitis B, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global burden of hepatitis B virus: current status, missed opportunities and a call for action. https://app.cochat.ai/papers/10.1038/s41575-023-00760-9
- The paper
- Hsu, Y.-C., Huang, D. Q., & Nguyen, M. H. (2023). Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-023-00760-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.